Benefits and harms of aspirin to reduce colorectal cancer risk: a cross-sectional study of methods to communicate risk in primary care
Peter Nguyen, Jennifer McIntosh, Adrian Bickerstaffe, Sanjaya Maddumarachchi, Kara-Lynne Cummings, Jon D Emery
BRITISH JOURNAL OF GENERAL PRACTICE | ROYAL COLL GENERAL PRACTITIONERS | Published : 2019
BACKGROUND: New Australian guidelines recommend that GPs actively consider prescribing low-dose aspirin to patients aged 50-70 years to reduce their risk of developing colorectal cancer (CRC). Patients and GPs need to understand the relative benefits and harms to support informed decision making. AIM: To develop and examine different methods to communicate the benefits and harms of taking aspirin for CRC prevention. DESIGN AND SETTING: A cross-sectional, vignette study with patients aged 50-70 years consecutively recruited from general practices in Melbourne, Australia, between July and August 2018. METHOD: Summary estimates from meta-analyses of the effects of aspirin on the incidence of CR..View full abstract
Peter Nguyen is a PhD candidate funded by an Australian Government Research Training Program. Jon Emery is funded by an Australian National Health Medical Research Council practitioner fellowship. This research was supported and funded by the Primary Care Collaborative Cancer Clinical Trials Group (PC4).